• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

18
18
18
10

COUNTRY

18

CATEGORIES

  • 27
  • 7
  • 2
  • 1
  • 1
  • 1

PRICE

27
28
32
38

PUBLISHED

1
2
11
38

PRODUCT TYPE

33
5

Search "inVentiv Health-Deals & Alliances Report" returned 38 results.

PRODUCT TITLE
Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements] Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements] - Product Thumbnail Image

Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements]

The Pharma and Biotech M&A Trends 2009-2014 report provides comprehensive understanding and unprecedented access to the merger and acquisition agreements entered into by the worlds leading biopharma...

July 2014
FROM

inVentiv Health, Inc. - SWOT, Strategy and Corporate Finance Report

inVentiv Health, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product...

August 2013
FROM

inVentiv Health, Inc - Strategic SWOT Analysis Review

inVentiv Health, Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed...

January 2014
FROM
inVentiv Health, Inc - Financial and Strategic SWOT Analysis Review inVentiv Health, Inc - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

inVentiv Health, Inc - Financial and Strategic SWOT Analysis Review

inVentiv Health, Inc - Financial and Strategic SWOT Analysis Review Summary inVentiv Health, Inc (inVentiv Health) is one of the leading providers of value-added services to the pharmaceutical, life...

March 2012
FROM

inVentiv Health, Inc. (formerly PharmaNet/i3) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain...

June 2014
FROM

Pharmaceutical Contract Sales Organizations (CSO) - Emerging Markets to Drive Growth but Talent Acquisition in Specialty Secondary Care Remains a Challenge

“Pharmaceutical Contract Sales Organizations (CSO) - Emerging Markets to Drive Growth but Talent Acquisition in Specialty Secondary Care Remains a Challenge” provides key data, information and analysis...

August 2010
FROM

Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

The Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements...

August 2013
FROM
Research Update: InVentiv Health Inc. 'B+' Corporate Credit, Other Ratings On CreditWatch Negative After Announcement May 11 Research Update: InVentiv Health Inc. 'B+' Corporate Credit, Other Ratings On CreditWatch Negative After Announcement May 11 - Product Thumbnail Image

Research Update: InVentiv Health Inc. 'B+' Corporate Credit, Other Ratings On CreditWatch Negative After Announcement May 11

Abstract InVentiv Health announced that is was acquiring contract research organization (CRO) PharmaNet Development Group. No financial terms have been disclosed. Standard & Poor's Ratings Services...

May 2011
InVentiv Health Inc. 'B+' Corporate Credit, Other Ratings On CreditWatch Negative After Announcement May 11 InVentiv Health Inc. 'B+' Corporate Credit, Other Ratings On CreditWatch Negative After Announcement May 11 - Product Thumbnail Image

InVentiv Health Inc. 'B+' Corporate Credit, Other Ratings On CreditWatch Negative After Announcement May 11

Abstract InVentiv Health announced that is was acquiring contract research organization (CRO) PharmaNet Development Group. No financial terms have been disclosed. Standard & Poor's Ratings Services...

May 2011
Research Update: InVentiv Health Inc. 'B+' Corporate Credit, Other Ratings Affirmed On Acquisition Announcements; Outlook Stable Feb 11 Research Update: InVentiv Health Inc. 'B+' Corporate Credit, Other Ratings Affirmed On Acquisition Announcements; Outlook Stable Feb 11 - Product Thumbnail Image

Research Update: InVentiv Health Inc. 'B+' Corporate Credit, Other Ratings Affirmed On Acquisition Announcements; Outlook Stable Feb 11

Abstract Sponsor-owned inVentiv Health plans to acquire contract research services provider i3 from Ingenix for $400 million and Campbell Alliance for roughly $140 million. The company will fund the...

February 2011
InVentiv Health Inc. 'B+' Corporate Credit, Other Ratings Affirmed On Acquisition Announcements; Outlook Stable Feb 11 InVentiv Health Inc. 'B+' Corporate Credit, Other Ratings Affirmed On Acquisition Announcements; Outlook Stable Feb 11 - Product Thumbnail Image

InVentiv Health Inc. 'B+' Corporate Credit, Other Ratings Affirmed On Acquisition Announcements; Outlook Stable Feb 11

Abstract Sponsor-owned inVentiv Health plans to acquire contract research services provider i3 from Ingenix for $400 million and Campbell Alliance for roughly $140 million. The company will fund the...

February 2011
Partnering Deals and Alliances with Big Biotech Partnering Deals and Alliances with Big Biotech - Product Thumbnail Image

Partnering Deals and Alliances with Big Biotech

The Partnering Deals and Alliances with Big Biotech report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty big biotech companies. Partnering...

August 2013
FROM
Cancer Monoclonal Antibody Partnering Terms and Agreements Cancer Monoclonal Antibody Partnering Terms and Agreements - Product Thumbnail Image

Cancer Monoclonal Antibody Partnering Terms and Agreements

The Cancer Monoclonal Antibody Partnering Agreements report provides an understanding and access to the cancer monoclonal antibody partnering deals and agreements entered into by the worlds leading...

October 2013
FROM
Infectious Vaccines Partnering Terms and Agreements Infectious Vaccines Partnering Terms and Agreements - Product Thumbnail Image

Infectious Vaccines Partnering Terms and Agreements

The Infectious Vaccines Partnering Terms and agreements report provides a detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals. The majority of deals...

December 2013
FROM
Cancer Diagnostics Partnering Terms and Agreements Cancer Diagnostics Partnering Terms and Agreements - Product Thumbnail Image

Cancer Diagnostics Partnering Terms and Agreements

The Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends...

June 2013
FROM
Antibiotics Partnering Terms and Agreements Antibiotics Partnering Terms and Agreements - Product Thumbnail Image

Antibiotics Partnering Terms and Agreements

The Antibiotics Partnering Agreements report provides an understanding and access to the antibiotics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends...

December 2013
FROM
Practical Guide to Finding Partners Practical Guide to Finding Partners - Product Thumbnail Image

Practical Guide to Finding Partners

Current Partnering’s Practical Guide to Finding Partners provides a comprehensive overview of all the steps required to identify and secure potential partnering opportunities either for an in-licensing...

September 2013
FROM
Industry Report Card: Medicare Cuts Loom As A Senior Factor in U.S. Health Care Company Ratings Oct 11 Industry Report Card: Medicare Cuts Loom As A Senior Factor in U.S. Health Care Company Ratings Oct 11 - Product Thumbnail Image

Industry Report Card: Medicare Cuts Loom As A Senior Factor in U.S. Health Care Company Ratings Oct 11

Abstract Third-party funding of essential care, along with continued high margins for patented medical treatments, has protected many U.S. for-profit health care industry participants from the difficulties...

October 2011
Industry Report Card: Ratings Outlook Remains Stable For U.S. For-Profit Health Care Companies May 12 Industry Report Card: Ratings Outlook Remains Stable For U.S. For-Profit Health Care Companies May 12 - Product Thumbnail Image

Industry Report Card: Ratings Outlook Remains Stable For U.S. For-Profit Health Care Companies May 12

Abstract Standard & Poor's Ratings Services expects ratings for 2012 on the U.S. for-profit health care sector to be stable. Our view reflects adequate or better liquidity for a high majority of issuers,...

May 2012
Industry Report Card: The Outlook For U.S. For-Profit Health Care Companies Is Stable, As They Face Challenging Industry Changes In 2013 May 13 Industry Report Card: The Outlook For U.S. For-Profit Health Care Companies Is Stable, As They Face Challenging Industry Changes In 2013 May 13 - Product Thumbnail Image

Industry Report Card: The Outlook For U.S. For-Profit Health Care Companies Is Stable, As They Face Challenging Industry Changes In 2013 May 13

Abstract Standard & Poor's Ratings Services expects its ratings on the U.S. for-profit health care companies it rates to remain broadly stable in 2013, with a modest negative bias, primarily in the...

May 2013
Loading Indicator